Plain-English translation of NCT01205815 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Melanoma research guide →Researchers at Vanderbilt-Ingram Cancer Center are building a research repository of tissue and blood samples from melanoma patients. The goal is to study the biological characteristics that help explain how melanoma develops and spreads, so that future treatments can be better targeted to individual patients.
Melanoma is a serious form of skin cancer, and doctors need to better understand the biological differences between tumors to improve treatment approaches. By collecting and studying tissue samples from many patients, researchers hope to discover new insights that could one day lead to more personalized and effective therapies.
You likely qualify if…
You likely don't qualify if…
If you participate, you may donate leftover tissue from a diagnostic or treatment procedure you're already having, or you may donate a blood sample during a visit. The researchers will store your samples in a secure research bank for use in future studies to understand melanoma better. There are no experimental drugs or special treatments involved—this is purely about contributing biological samples to advance research knowledge.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Enrollment target
~3,000 participants
Started
June 2010
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.